Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Client SatisfactionMintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. has a strong record in IPOs, follow-on offerings and SPAC transactions, particularly in the life sciences sector. It continued to advise on a series of de-SPAC deals in 2023 and represents both issuers and underwriters. Focused on mid-cap domestic offerings, the capital markets team has some pedigree in cross-border deals; it launched a life sciences-focused Toronto office in 2023. Boston partners Jonathan Kravetz and William Hicks are key figures in the team.
Legal 500 Editorial commentary
Key clients
- QIAGEN N.V.
- ProKidney LP
- Vicarious Surgical
- G1 Therapeutics, Inc.
- Aspen Aerogels, Inc.
- Molecular Templates, Inc.
- Myriad Genetics
- WAVE Life Sciences Ltd.
- Pieris Pharmaceuticals, Inc.
- EcoR1 Capital
Practice head
The lawyer(s) leading their teams.
Michael Fantozzi, William Hicks, Jonathan Kravetz